Medi-MIBI

Tc-MR-1

Indications

After radiolabelling with sodium pertechnetate (99mTcsolution, the solution obtained is indicated for:

Myocardial perfusion scintigraphy for the detection and localisation of coronary artery disease (angina pectoris and myocardial infarction) Assessment of global ventricular function. First-pass technique for determination of ejection fraction and/or ECG-triggered, gated SPECT for evaluation of left ventricular ejection fraction, volumes and regional wall motion.
Scintimammography for the detection of suspected breast cancer when mammography is equivocal, inadequate or indeterminate.
Localisation of hyperfunctioning parathyroid tissue in patients with recurrent or persistent disease in both primary and secondary hyperparathyroidism, and in patients with primary hyperparathyroidism scheduled to undergo initial surgery of the parathyroid glands.

Labelling activity
Maximum 15 GBq (405.41 mCi)

Shelf life
30 months

Shelf-life and storage conditions after radiolabelling
8 hours, Do not store above 25°C.

Medi-RadioPharma is a long-established producer and distributor of radiopharmaceuticals, sealed radiation sources, and calibration standards for nuclear medicine, research, and industrial applications. With a portfolio covering diagnostic and therapeutic isotopes, generators, and custom-made radioactive preparations, Medi-RadioPharma serves hospitals, laboratories, and industrial partners across international markets.

Through its partnership with Van Overeem Nuclear B.V., Medi-RadioPharma enhances its service offering: Van Overeem’s Sources Made Easy concept provides customers with convenient multi-annual agreements for the delivery of new sources and the safe disposal of depleted ones, fully tailored to departmental needs.

Together, Medi-RadioPharma and Van Overeem Nuclear B.V. deliver a comprehensive, reliable solution for isotope supply, logistics, and lifecycle management — ensuring high-quality, compliant support for medical imaging, therapy, research, and industrial processes.

Serving our global clients with (radio)-pharmaceuticals and radiochemical grade radionuclides.

Van Overeem Nuclear bv

Minervum 7070
4817 ZK Breda
The Netherlands

phone:

+31 (0)76 8200970

email:

sales@vonbv.com